Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424860
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-04-29
Brief Title:
Fish Oil Metformin and Heart Health in PCOS
Sponsor:
University of Alberta
Organization:
University of Alberta
Study Overview
Official Title:
Dietary Fish Oil and Metformin Intervention for Heart Health in PCOS
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Women with Polycystic Ovary Syndrome PCOS have high testosterone levels which is associated with altered insulin-glucose metabolism and an adverse blood lipid profile predisposing them to the development of Type II Diabetes and Cardiovascular Disease CVD This study will investigate the use of dietary fish oil supplementation as a safe and effective intervention and as an adjunct therapy to standard of care treatment with metformin to improve heart health blood lipids and insulin-glucose metabolism in women with PCOS and those with PCOS and Type 2 Diabetes
Detailed Description:
OBJECTIVES The objective in this proposed study is to determine the effect of dietary fish oil supplementation with metformin compared to standard of care metformin-alone treatment for 12 months on plasma lipids and apoB- remnant lipoprotein metabolism and atherosclerotic cardiovascular disease and cardiac function in high-risk overweight-obese young individuals with PCOS
This study will provide evidence-based research on the efficacy of fish oil in the form as an adjunct therapy to standard treatment with metformin as a safe nutritional treatment to add to therapeutic guidelines to reduce early CVD risk in young women with PCOS
Specific Objectives
1 To quantify carotid intimal medical thickness cIMT and plaque height before and after the intervention to assess the effect of fish oil supplementation combined with metformin standard of care on atherosclerotic cardiovascular disease and cardiac function
2 To determine the effects of dietary fish oil supplementation combined with metformin and metformin standard of care on fasting and non-fasting plasma TG apoB48 and apoB100-lipoprotein concentrations and cardiac function variables including left ventricular LV posterior wall thickness LV ejection fraction
3 To assess the effect of dietary fish oil supplementation on insulin glucose and endocrine parameters
This study will provide evidence-based research on the efficacy of fish oil in the form as an adjunct therapy to standard treatment with metformin as a safe nutritional treatment to add to therapeutic guidelines to reduce early CVD risk in young women with PCOS
Specific Objectives
1 To quantify carotid intimal medical thickness cIMT and plaque height before and after the intervention to assess the effect of fish oil supplementation combined with metformin standard of care on atherosclerotic cardiovascular disease and cardiac function
2 To determine the effects of dietary fish oil supplementation combined with metformin and metformin standard of care on fasting and non-fasting plasma TG apoB48 and apoB100-lipoprotein concentrations and cardiac function variables including left ventricular LV posterior wall thickness LV ejection fraction
3 To assess the effect of dietary fish oil supplementation on insulin glucose and endocrine parameters
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None